Search results
Results from the WOW.Com Content Network
Seven national agencies in the country initially formed part of the Dangerous Drugs Board. These are the Department of Health, Department of Social Service and Development (now Department of Social Welfare and Development), Department of Education, Culture and Sports (now Department of Education), Department of Justice, Department of National Defense, Department of Finance and the National ...
The DrugBank Online website is available to the public as a free-to-access resource. However, use and re-distribution of content from DrugBank Online or the underlying DrugBank Data, in whole or part, and for any purpose requires a license. Academic users can apply for a free license for certain use cases while all other users require a paid ...
The Philippine Drug Enforcement Agency (PDEA, / p iː ˈ d eɪ ə /; [1] Filipino: Ahensiya ng Pilipinas sa Pagpapatupad ng Batas Laban sa Bawal na Gamot [2]) is the lead anti-drug law enforcement agency, responsible for preventing, investigating and combating any dangerous drugs, controlled precursors and essential chemicals within the Philippines.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The law took effect on June 22, 2002, 15 days after it was signed by Gloria Macapagal Arroyo.Its primary implementing agency is the Philippine Drug Enforcement Agency.The list of illegal drugs may be modified by the DDB through a proceeding initiated by the PDEA, the Department of Health, or any petition by a concerned party.
Although it is free of copyright restrictions, this image may still be subject to other restrictions. See WP:PD § Fonts and typefaces or Template talk:PD-textlogo for more information. This work includes material that may be protected as a trademark in some jurisdictions.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as atopic dermatitis (eczema), asthma and nasal polyps which result in chronic sinusitis.